Navigation Links
Medbox, Inc. Announces Approval in Colorado House Bill (HB1043)
Date:12/28/2011

HOLLYWOOD, Calif., Dec. 28, 2011 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that their Medbox™ Prescription Dispensing System has been cited by the Colorado State Legislature in HB1043.

Colorado House Bill (HB1043) clarifies certain aspects of the law and the regulations pertaining to the dispensing of alternative medicines.  The bill requires greater transparency for owners and operators of clinics, and classifies customer files as Medical Records, which are subject to the state's Medical Records Statute.

Medbox™ is the only biometrically controlled system that provides prescription medicine dispensing with automated record keeping and full transparency. The Medbox™ system will organize, track, and dispense medications, with sophisticated inventory management and customizable reports.

"Our system has been endorsed and approved by government officials, because it takes the alternative medicine clinic out of the backroom and into full compliance with all state regulations," stated Vincent Mehdizadeh, CEO and Founder of Prescription Vending Machines, Inc, a subsidiary of Medbox, Inc. "Not only does our system ensure that only authorized individuals receive the medicine, but it provides an unalterable record of transactions for taxation reporting and clarity."

Medbox™ is the world's first medical dispensing system to feature a patented biometric fingerprint recognition program, which assures patient identity and provides military grade security.

For more information on Medbox, Inc. please call the Investor Relations Department at (800) 766-1452 or go online to www.medboxinc.com

Medbox is listed on the OTC Board, ticker symbol MDBX.

About Medbox: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled, di
'/>"/>

SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
2. NIAID announces 25 new awards to develop radiation countermeasures
3. Aware Announces Q3 2008 Earnings Conference Call
4. Governor Doyle announces historic genomic research collaboration
5. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
6. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
7. Parkinsons Disease Foundation announces award of $150,000
8. Jefferson Department of Surgery announces new pancreas tumor registry
9. NAS announces initiative to connect entertainment industry with top experts
10. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
11. VUANCE Announces Crime Scene Security and Evidentiary Tracking Development Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... The White House honored Clemson professor Rajendra Singh ... efforts to promote and expand solar deployment in ... the D. Houser Banks Professor of Electrical and ... Silicon Nanoelectronics, is considered a local hero leading ... and economic opportunity in solar power and driving ...
(Date:4/17/2014)... many serious conditions such as heart disease, epilepsy and ... therapies. Unfortunately, there is still much scientists do not ... and unexpected insight into the structure of sodium channels ... - which are responsible for ,fine-tuning, the activity of ... recent edition of the Journal of Biological Chemistry ...
(Date:4/17/2014)... at the University of Texas Medical Branch at ... women treated with radiation for cervical cancer should ... , The UTMB researchers, finding a high ... survivors treated with radiation, offer new recommendations that ... cancer screening about eight years after their initial ...
Breaking Biology News(10 mins):White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2
... of the genetic code -- resembles road traffic, including ... the flow of vehicles. This surprising finding, reported recently ... might facilitate the development of a new generation of ... involves a step resembling the motion of a vehicle: ...
... International Union of Nutritional Science (IUNS) 20th Congress ... September 2013, will gather nutrition experts from around the ... conjunction with the Congress on 19 September, a Symposium ... of dairy in prevention of metabolic syndrome, CVD, obesity ...
... large hydroelectric dams already in question, scientists are reporting ... world make an important contribution to the greenhouse gases ... more methane than previously believed bubbles out of the ... Environmental Science & Technology . Andreas Maeck and ...
Cached Biology News:Gene decoding obeys road traffic rules 2'Exploring the Latest Evidence of Dairy's Contribution to Nutrition at IUNS Satellite Symposium' 2'Exploring the Latest Evidence of Dairy's Contribution to Nutrition at IUNS Satellite Symposium' 3
(Date:1/15/2014)... January 15, 2014 DTS Language Services, ... Online Web Portal for Life Science organizations who need document ... the subject matter of their documents in advance with a ... reduce time-to-delivery of translations, often a critical factor in clinical ...
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have ... at 2pm EST (11am PST), “Natural Language Processing: Converting ... how technology can turn raw, heterogeneous data into actionable ... The online webinar will last approximately one hour. , ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up ... many of them wrote: "Take better care of my furry companion." ... designer clothes and top-brand carrying cases to take the little canine ... might also feel compelled to buy some pricey toys at the ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... Call Tomorrow (Tuesday) at 8:30 am EDT to ... Discuss the Clinical ... (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced,the initiation ... norepinephrine reuptake inhibitor (SNRI) - for the treatment of,diabetic neuropathic pain. ...
... CeloNova BioSciences, Inc.,("CeloNova"), a leading developer of ... fully color-coded line of embolic particles,Embozene(TM) Color-Advanced ... and Interventional Radiology Society of Europe (CIRSE) ... ) Embolic microspheres are used to ...
... 7 Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced ... to present a corporate overview at the,ThinkEquity Partners, G5: ... p.m. Eastern Time (10:30 a.m. Pacific Time) at the ... the live audio broadcast or the subsequent archived,recording, log ...
Cached Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7CeloNova BioSciences Announces World's First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres 2Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Request Info...
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Polyclonal Antibody to TRIB1/ SKIP1/ Tribbles 1...
Biology Products: